1204858

Sciegen Pharmaceuticals Inc — FEI 3008298016

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional Details

Bioanalytical BA/BE